Cost-Effectiveness Analysis of Durvalumab in Limited-Stage Small Cell Lung Cancer in the United States

Publication Date

2025

Content Type

article

PubMed ID:

41418077

Additional Authors:

Additional Authors and Institutional Affiliations

This document is currently not available here.

Share

COinS